PML and pachyonychia congenita: We recently showed that knockdown of E6AP attenuates the growth of PC cells in vitro and in vivo, and that this effect is mediated, in part, through an E6AP-target we previously identified [12]: the tumor suppressor Promyelocytic Leukaemia protein (PML).